Blood News and Research

RSS

Chemical in veggies help heal fatty liver

A new study shows that a compound naturally occurring in a variety of commonly used vegetables as well as being produced by gut microbes is very useful in melting fat away from a fatty liver.

9 Feb 2020

High bacterial levels in half of lupus skin rashes

A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of viable staph bacteria. This makes them more susceptible to skin infections and also increases the risk that the infection will spread to others.

9 Feb 2020

Growing eggs and sperm to treat infertility

Scientists at the University of California, Los Angeles, have reported, in the journal Cell Reports, the mechanism of how the very early precursor or stem cells which eventually give rise to the germ cells, eggs and sperm, are formed over the course of development. This could help create eggs and sperms under laboratory conditions to help infertile people who don’t have sperms, or eggs, for instance.

9 Feb 2020

Discovery of potential cause of age-related macular degeneration

Age related macular degeneration or AMD leads to loss of vision in around 1.5 million people in the United Kingdom and millions of others around the world. In a new study researchers have discovered a new protein that could explain the causation and thus provide clues to its early diagnosis and effective treatment. The study was published in the latest issue of the journal Nature Communications.

9 Feb 2020

Viagra may cause long lasting visual disturbances finds study

In a new study scientists have reported that Sildenafil or Viagra pills used for erectile dysfunction could lead to longer lasting visual disturbances than known before. The study titled, “Ocular Side Effects of Sildenafil That Persist Beyond 24 h—A Case Series,” was published in the latest issue of the journal Frontiers in Neurology.

9 Feb 2020

CRISPR-edited immune cells can be safely given to cancer patients

The emergence of CRISPR-Cas9 gene-editing technology has spurred hope in both doctors and patients since it shows promise in treating a multitude of diseases, including cancer. For the first time in the United States, a team of scientists has shown that CRISPR-edited immune cells can be safely used to cancer patients.

9 Feb 2020

Fingerprint test can identify cocaine users

Cocaine is a powerful and addictive stimulant made from coca plant leaves, which is native to South America. In the past urine and saliva tests are used to detect cocaine use. Now, a new fingerprint test can detect whether people have taken the drug or just handled it.

9 Feb 2020

Robot that can draw blood in humans

Soon, robots can take blood samples that can benefit both patients and healthcare workers, thanks to a new blood-sampling robot. A few years back, it was developed but was only tested on plastic arms. Now, the robot has been successfully trialed on live humans.

9 Feb 2020

Study identifies potential drug target and way to alleviate cerebral malaria

Scientists have identified a key molecule involved in the development of cerebral malaria, a deadly form of the tropical disease. The study identifies a potential drug target and way forward toward alleviating this condition for which few targeted treatments are available.

9 Feb 2020

St. Jude's researchers receive ACGT grant to tackle challenges of pediatric sarcomas

An innovative approach to tackling the challenges of pediatric sarcomas is being pursued by researchers at St. Jude Children's Research Hospital (Memphis, Tennessee) with a new grant from Alliance for Cancer Gene Therapy.

9 Feb 2020

New strategies needed to reduce pneumococcal meningitis rates

Pneumococcal conjugate vaccine have been highly effective in reducing pneumonia and other invasive infections caused by Streptococcus pneumoniae bacteria.

9 Feb 2020

Understanding the genetic background of idiopathic ketotic hypoglycemia

Lisa is two years old. She often gets uneasy--shaking and sweating--especially in the morning. She vomits and refuses to eat. Her mother, Karoline, knows she has to act before Lisa starts to deteriorate.

9 Feb 2020

Acute Cardiovascular Care 2020 will highlight novel research on recovery from heart emergencies

Innovative research in the diagnosis and treatment of heart emergencies will be revealed at Acute Cardiovascular Care 2020, a scientific congress of the European Society of Cardiology.

9 Feb 2020

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

A research group led by Professor NISHIMURA Noriyuki (Graduate School of Health Sciences, Kobe University) has developed a new method to monitor the residual disease after treatment in high-risk neuroblastoma patients.

9 Feb 2020

Scientists identify new biomarker for identifying individuals at risk of depression

Chronic pain, or inflammation, is believed to be one of the major factors in the onset of major depressive disorder.

8 Feb 2020

Researchers offer new hope for diagnosis, treatment of age-related macular degeneration

Researchers have identified a new protein linked to age-related macular degeneration (AMD) that could offer new hope for the diagnosis and treatment of the disease, which affects over 1.5 million people in the UK alone.

8 Feb 2020

New guidelines recommend no-biopsy approach for childhood celiac disease diagnosis

The European Society for Paediatric Gastroenterology, Hepatology and Nutrition has today issued new guidance to physicians on the diagnosis of celiac disease in children recommending the no-biopsy approach at diagnosis for the majority of children suspected of having the disease.

7 Feb 2020

Researchers develop a new way of making bone-replacement materials

A new way of making bone-replacement materials that allows for cells to grow around and inside them has been developed by researchers at the University of Birmingham.

6 Feb 2020

Increasing the number of small blood vessels may be helpful for recovering movement

Many health conditions - ranging from disease of particular organs such as heart and lungs, widespread metabolic issues such as diabetes, or following trauma such as spinal cord injury – cause difficulties with movement.

6 Feb 2020

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor natural killer (NK)-cell therapy targeting CD19 resulted in clinical responses in a majority of patients with relapsed or refractory non-Hodgkin's lymphoma and chronic lymphocytic leukemia, with no major toxicities observed.

6 Feb 2020

Blood News and Research

Chemical in veggies help heal fatty liver

High bacterial levels in half of lupus skin rashes

Growing eggs and sperm to treat infertility

Discovery of potential cause of age-related macular degeneration

Viagra may cause long lasting visual disturbances finds study

CRISPR-edited immune cells can be safely given to cancer patients

Fingerprint test can identify cocaine users

Robot that can draw blood in humans

Study identifies potential drug target and way to alleviate cerebral malaria

St. Jude's researchers receive ACGT grant to tackle challenges of pediatric sarcomas

New strategies needed to reduce pneumococcal meningitis rates

Understanding the genetic background of idiopathic ketotic hypoglycemia

Acute Cardiovascular Care 2020 will highlight novel research on recovery from heart emergencies

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

Scientists identify new biomarker for identifying individuals at risk of depression

Researchers offer new hope for diagnosis, treatment of age-related macular degeneration

New guidelines recommend no-biopsy approach for childhood celiac disease diagnosis

Researchers develop a new way of making bone-replacement materials

Increasing the number of small blood vessels may be helpful for recovering movement

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News